Wednesday, June 28, 2017 6:55:22 AM
"The Multi-Billion Dollar North American Cannabis Market; Publicly Traded Company Directory Preview Released"
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
http://www.todayinhealthcare.com
Quote:
"One area where lab testing is absolutely set to expand significantly is California—the largest single producer and consumer of cannabis in America—where none of the marijuana is subject to state quality-control standards and may be sold as-is until Jan. 1, 2018."
MYDX is proving CannaDX is reliable for the everyday cannabis consumer to "trust & verify" to determine before inhaling if that is the strain that the consumer intended to put in their body. They will do this before 2018 by the time its required for dispensaries to follow quality standards.
Medicinal cannabis sector will be revolutionized with the release of "Powered By MYDX" medicinal cannabis vape pens which will cater to the specific needs of doctors looking to remedy the specific needs of the patients with the direct ability to measure effectiveness of doses through the vape pens ability by design to communicate via bluetooth to smart devices.
https://finance.yahoo.com/news/mydx-enters-80-000-mydx360-130000842.html?.tsrc=applewf
The whole thing is great, but this is my favorite part:
Quote:
"The MyDx360 platform makes it incredibly easy for market players to create new high quality tailored formulations that can support their customer's needs. It also speaks to our ability as a company to execute on our vision of creating a brand centric ecosystem powered by community driven data."
http://www.wandtv.com/story/35675235/mydx-launches-canadian-national-marketing-campaign-to-promote-transparency-and-prevent-abuse-with-its-cannadx-cannabis-handheld-chemical-analyzer
Good news travels fast and free.
Quote:
"Aphria (APH), one of Canada’s largest licensed Marijuana grower’s, called on the government to determine “clear and enforceable rules to ensure that customers are protected and have access to clean and safe products.” Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."
Big Pharma let MYDX take the risk? Is it because Big Pharma knows it will be years before cannabis becomes legal at federal level even though it is becoming legal by the states? Is it because Big Pharma knows they can just buy into MYDX's first to market smart medicinal cannabis vape pens due to market availability by end of this year? Big Pharma will have to go through MYDX?
Is it because Big Pharma knows they can just buy their way in? Why no big pharma producing a smart vape pen in the medicinal cannabis market that communicates data by Bluetooth? Don't they have significant resources and ability or will they just buy their way in because they know MYDX is already doing it and plans on bringing the product to market by end of year? What effect will that have on current shareholders?
"You will not find another multi-billion-dollar market growing at 25 percent anywhere in the world that is not already filled with multi-national companies and institutional investors" - Arcview Market Research"
(Link to follow)
MYDX, the best kept secret on this list of companies. Investors will be buying indefinitely into MYDX when they hear about MYDX's current product on the market and all of MYDX's products to be on the market. I believe investors will buyin much less before all products hit the market. It will be a scramble I believe for investors to get in under .025 with enough exposure.
http://www.investorideas.com/news/2017/marijuana/02061Directory.asp
http://www.todayinhealthcare.com
Quote:
"One area where lab testing is absolutely set to expand significantly is California—the largest single producer and consumer of cannabis in America—where none of the marijuana is subject to state quality-control standards and may be sold as-is until Jan. 1, 2018."
MYDX is proving CannaDX is reliable for the everyday cannabis consumer to "trust & verify" to determine before inhaling if that is the strain that the consumer intended to put in their body. They will do this before 2018 by the time its required for dispensaries to follow quality standards.
Medicinal cannabis sector will be revolutionized with the release of "Powered By MYDX" medicinal cannabis vape pens which will cater to the specific needs of doctors looking to remedy the specific needs of the patients with the direct ability to measure effectiveness of doses through the vape pens ability by design to communicate via bluetooth to smart devices.
https://finance.yahoo.com/news/mydx-enters-80-000-mydx360-130000842.html?.tsrc=applewf
The whole thing is great, but this is my favorite part:
Quote:
"The MyDx360 platform makes it incredibly easy for market players to create new high quality tailored formulations that can support their customer's needs. It also speaks to our ability as a company to execute on our vision of creating a brand centric ecosystem powered by community driven data."
http://www.wandtv.com/story/35675235/mydx-launches-canadian-national-marketing-campaign-to-promote-transparency-and-prevent-abuse-with-its-cannadx-cannabis-handheld-chemical-analyzer
Good news travels fast and free.
Quote:
"Aphria (APH), one of Canada’s largest licensed Marijuana grower’s, called on the government to determine “clear and enforceable rules to ensure that customers are protected and have access to clean and safe products.” Other licensed producers are also starting to take measures to self-regulate and go above and beyond the regulatory requirements until further defined. The MyDx handheld analyzer for Cannabis (also known as CannaDx) goes hand in hand with those efforts to identify important chemicals profiles and the effects on consumers. This is a very unique opportunity for Canadian producers and MyDx to work together to track feedback from consumers that is tied directly to a chemical profile with over 48,000 datasets collected to date."
Big Pharma let MYDX take the risk? Is it because Big Pharma knows it will be years before cannabis becomes legal at federal level even though it is becoming legal by the states? Is it because Big Pharma knows they can just buy into MYDX's first to market smart medicinal cannabis vape pens due to market availability by end of this year? Big Pharma will have to go through MYDX?
Is it because Big Pharma knows they can just buy their way in? Why no big pharma producing a smart vape pen in the medicinal cannabis market that communicates data by Bluetooth? Don't they have significant resources and ability or will they just buy their way in because they know MYDX is already doing it and plans on bringing the product to market by end of year? What effect will that have on current shareholders?
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.